SUPREMO Selective Use of Postoperative Radiotherapy after Mastectomy / NHS Scotland

Welcome to SUPREMO

Welcome to the SUPREMO breast cancer trial. SUPREMO stands for;

Selective Use of Postoperative Radiotherapy aftEr MastectOmy.

We have divided our website into three different areas with different kinds of information to meet your needs. They are:

  • A patient area where you will find information about the trial if you are a patient taking part, or thinking about whether to take part
  • An area for participating investigators where you can find out about progress in the trial and exchange information with other practitioners.
  • An area for potential investigators who are thinking about joining the trial where you can find out more about what is involved.

Please click on the logos to the left, for links to the MRC (Medical Research Council), BIG (Breast International Group) and EORTC (European Organisation for Research and Treatment of Cancer) websites.

The SUPREMO trial is sponsored by the UK Medical Research Council (MRC), which is a national organisation funded by the UK taxpayer.

The MRC promotes research into all areas of medical and related science with the aims of improving the health and quality of life of the UK public and contributing to the wealth of the nation.

Over the last decade MRC discoveries have helped improve people's health in the UK and worldwide, and continued to build a foundation for future biomedical progress.

MREC Ref: 05/50501/106
ISRCTN61145589

© SUPREMO 2010
Scottish Clinical Trials Research Unit
Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB
Site Map | Feedback | Privacy
NHS Lothian University of Edinburgh ISD Scotland NHS National Services Scotland